Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

TriLink Announces New License Agreement with Biofortuna

Published: Friday, November 08, 2013
Last Updated: Friday, November 08, 2013
Bookmark and Share
Agreement for use of CleanAmp™ dNTPs in Biofortuna’s freeze-drying contract development and production service.

TriLink BioTechnologies, Inc. (TriLink) has announced that it has signed a new licensing agreement with Biofortuna Ltd. (Biofortuna) for use of its CleanAmp™ dNTPs in Biofortuna’s freeze-drying (lyophilized) contract development and production service.

In 2010 Biofortuna licensed TriLink’s CleanAmp™ dNTPs for use in their unique molecular diagnostic kits, SSPGo™, which are now distributed exclusively by Abbott Molecular for the HLA, transplantation, disease ID and PGx market.

The expanded CleanAmp™ license gives Biofortuna the right to incorporate CleanAmp™ dNTPs into their recently-launched freeze-drying molecular diagnostic kit development and production service.

When developing SSPGo™ (complete freeze dried PCR reaction kits stabilized at ambient temperatures for up to 16 months) CleanAmp™ dNTPs gave Biofortuna a viable Hot Start PCR alternative that improved specificity by simple replacement of standard dNTPs with CleanAmp™ dNTPs.

Now the advantages of these combined technologies are available to all diagnostic kit developers.

At the upcoming Association of Molecular Pathology (AMP) Annual Meeting, TriLink and Biofortuna will host a corporate workshop entitled “Freeze Dried Hot Start PCR Mixes - The Evolution of Molecular Diagnostics.”

This presentation will provide detailed information on each technology and how they come together through Biofortuna’s freeze dried kit development and production service to provide a superior molecular diagnostic product.

Dr. Mike Bunce, Biofortuna CSO commented, “We are delighted to have extended our agreement with TriLink which allows Biofortuna to offer hot start lyophilized mixes to diagnostic companies looking to develop stabilized molecular diagnostic kits.”

“Biofortuna’s continued breakthroughs in lyophilized assay development further highlight the versatility of CleanAmp™ dNTPs as an easy-to-use Hot Start reagent,” said Dr. Natasha Paul, TriLink Sr. Scientific Investigator.

“Biofortuna’s great success with their SSPGo™ product represents to us the real impact the CleanAmp™ technology can have on the evolution of molecular diagnostics. We’re very pleased that Biofortuna’s new lyophilized contract service business will provide an easy path for other kit developers to realize the advantages of CleanAmp™,” said TriLink CEO, Dr. Richard Hogrefe.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

TriLink Secures Contract for the Synthesis of Ebola Vaccine
The project aims to create a trivalent vaccine effective against aerosolized exposure to Ebola.
Friday, December 12, 2014
TriLink to Open New Early Phase Therapeutic Manufacturing Facility
Company's new 2,000 square foot diagnostic and pharmaceutical GMP production facility will be fully operational July 2014.
Tuesday, May 27, 2014
TriLink BioTechnologies Announces Agreement with American Cleanroom Systems to build cGMP Facility
Agreement signed to build a 2,000 square foot pharmaceutical cGMP production suite within San Diego facility.
Thursday, October 24, 2013
Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies
Dr. Gerald Zon, noted scientist in the field of nucleic acid research recently launched a new blog in conjunction with TriLink Biotechnologies.
Tuesday, May 21, 2013
TriLink BioTechnologies Announces Worldwide License with QuantiBact A/S
TriLink BioTechnologies, Inc. announced that it has signed a licensing agreement with QuantiBact A/S to offer twisted intercalating nucleic acid (TINA) modified oligos.
Thursday, May 16, 2013
TriLink BioTechnologies Announces Worldwide License with QuantiBact A/S
TriLink BioTechnologies Inc. announced that it has signed a licensing agreement with QuantiBact A/S to offer twisted intercalating nucleic acid (TINA) modified oligos.
Thursday, May 09, 2013
TriLink Enters into Distribution Agreement with Astral Scientific
The agreement allows Astral to sell Trilink's modified nucleic acid products, including over 150 modified nucleotides, custom oligonucleotides and CleanAmp™ Hot Start PCR Products. The Australian based company supplies clinical diagnostic, life science and industrial markets.
Tuesday, November 15, 2011
TriLink Announces License Agreement with Lucigen Corporation
Two companies have signed a licensing agreement for the use of TriLink’s CleanAmp™ dNTPs in Lucigen’s new Taq98™ Hot Start 2X MasterMix.
Wednesday, August 03, 2011
TriLink BioTechnologies, Inc. Awarded European Patent
TriLink BioTechnologies, Inc. announces the award of their CleanAmp™ Primer patent by the European Patent Office (EPO Patent no. 2032714).
Tuesday, May 31, 2011
TriLink Enters into Distribution Agreement with TATAA Biocenter
TriLink BioTechnologies, Inc. has entered into a distribution agreement with TATAA Biocenter (TATAA) to sell its CleanAmp™ Products.
Monday, March 28, 2011
TriLink BioTechnologies Awards Webster University CleanAmp™ ResearchReward
Dr. Mary Lai Preuss of Webster University has been given the award for map-based cloning of Arabidopsis root hair developmental mutants.
Friday, September 24, 2010
TriLink BioTechnologies, Inc. Announces License Agreement with Biofortuna Ltd
TriLink BioTechnologies, announced that it has signed a licensing agreement with Biofortuna Ltd. for use of CleanAmp™ dNTPs in Biofortuna’s freeze dried in vitro diagnostic PCR kits.
Tuesday, September 14, 2010
TriLink Enters Into Distribution and Supply Agreement with Affymetrix
Under the terms of agreement, Affymetrix will use TriLink's high quality oligonucleotides in several of their kits.
Wednesday, July 21, 2010
TriLink Awarded SBIR Phase II Grant: Chemical Determinants of DNA Ligase Fidelity
The National Institutes of Health recently awarded TriLink BioTechnologies, Inc. (TriLink) a Phase II SBIR Grant of approximately $725,000 to continue their work on developing reagents to enhance the specificity of DNA ligase.
Tuesday, June 22, 2010
TriLink BioTechnologies, Inc. Announces Supply Agreement with ETS Laboratories
TriLink BioTechnologies, Inc. (TriLink) announced that it has signed an agreement with ETS Laboratories (ETS) to supply CleanAmp™ dNTPs for use in their Scorpions™ Wine Spoilage Detection System.
Tuesday, April 27, 2010
Scientific News
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
How Cell Growth Triggers Cell Division
Researchers in Jan Skotheim's lab have discovered a previously unknown mechanism that controls how large cells grow, an insight that could one day provide insight into attacking diseases such as cancer.
Microbe Sleuth
Tanja Bosak examines how life and the Earth evolved in tandem during their early history together.
3 Ways Viruses Have Changed Science for the Better
Viruses are really good at what they do, and we’ve been able to harness their skills to learn about – and potentially improve – human health in several ways.
Restoring Vision with Stem Cells
Age-related macular degeneration (AMRD) could be treated by transplanting photoreceptors produced by the directed differentiation of stem cells, thanks to findings published today by Professor Gilbert Bernier of the University of Montreal and its affiliated Maisonneuve-Rosemont Hospital.
The Age of Humans Controlling Microbes
Engineered bacteria could soon be used to detect environmental toxins, treat diseases, and sustainably produce chemicals and fuels.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
Metabolomic Platform Reveals Fundamental Flaw in Common Lab Technology
A new study led by scientists at The Scripps Research Institute (TSRI) shows that a technology used in thousands of laboratories, called gas chromatography mass spectrometry (GC-MS), fundamentally alters the samples it analyzes.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos